Cathie's Ark Logo
undefined Logo

ARKG Holdings of Beam Therapeutics (BEAM) - Updated Daily

TherapeuticsGene TherapyGenomicsGene Base Editing
Date
Direction
Shares
Fund Weight
Fund
August 14, 2024
SELL185.0000.0003%ARKG
August 13, 2024
SELL1.776k0.0033%ARKG
August 12, 2024
SELL4.250k0.0079%ARKG
August 9, 2024
SELL2.040k0.0038%ARKG
August 8, 2024
SELL2.041k0.004%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
0%$1.93b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
38🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
173$70.44
🎫ARK Ownership Percent
0%

Other ETFs That Hold BEAM

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.87%
GNOMGlobal X Genomics & Biotechnology ETF3.11%
ARKKARK Innovation ETF2.92%
XBISPDR® S&P Biotech ETF0.94%
IBBiShares Biotechnology ETF0.22%
LABUS&P Biotech Bull 3X Shares ETF0.204%

Research Notes and Commentary for BEAM

No Research Notes Found for BEAM